Lixte Biotechnology Holdings Inc. buy Amped
Start price
20.04.22
/
0%
€12.00
Target price
20.04.23
-
Performance (%)
-50.00%
End price
21.04.23
€6.00
Summary
This prediction ended on 21.04.23 with a price of €6.00. The BUY prediction by Amped for Lixte Biotechnology Holdings Inc. performed very badly with a performance of -50.00%. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Lixte Biotechnology Holdings Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to Amped what are the pros and cons of Lixte Biotechnology Holdings Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Capable Management
Differentiated customer and product portfolio
Innovative
Very Future proof/growth oriented business model
Small cyclical dependencies
Cons
Comments by Amped for this prediction
In the thread Lixte Biotechnology Hldgs Inc. diskutieren
Buy Lixte Biotechnology Hldgs Inc.
In the thread Trading Lixte Biotechnology Hldgs Inc.
Die von Amped gewählte maximale Laufzeit wurde überschritten